We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Breath-Test Helps Diagnosis of Delayed Gastric Emptying

By LabMedica International staff writers
Posted on 07 May 2015
Print article
Image: A stable gas isotope ratio mass spectrometer (Photo courtesy of Thermo Scientific).
Image: A stable gas isotope ratio mass spectrometer (Photo courtesy of Thermo Scientific).
The Gastric Emptying Breath Test (GEBT) is a new noninvasive test to aid in the diagnosis of delayed gastric emptying, known as gastroparesis and has been officially approved.

Current tests used to diagnose gastroparesis typically involve the use of a small amount of radioactive material or imaging equipment, so testing must be conducted in specialized outpatient centers; however the GEBT can be used in broader settings.

According to the US Food and Drug Administration (FDA; Silver Spring, MD, USA) who have approved the GEBT, scientists conducted a clinical study using data from 115 participants who would typically undergo a gastric emptying test. All participants underwent testing with both the GEBT and gastric scintigraphy; the standard of care for measuring gastric emptying that requires ingestion of a test meal containing a radioactive material.

The GEBT, conducted over a four-hour period after an overnight fast, is designed to show how fast the stomach empties solids by measuring carbon dioxide in a patient’s breath. Patients have baseline breath tests conducted at the beginning of the test. They then eat a special test meal that includes a scrambled egg-mix and Spirulina platensis, a type of protein that has been enriched with carbon-13, which can be measured in breath samples.

Carbon-13 (13C) is a naturally existing non-radioactive form of the common element carbon-12 (12C). Both 12C and a very small amount of 13C are normally found in exhaled carbon dioxide. By adding 13C to the test meal, the GEBT can determine how fast the stomach empties the meal by measuring the ratio of 13C to 12C collected in breath samples at multiple time points after the meal is consumed compared to baseline utilizing a gas isotope ratio mass spectrometer.

The scientists compared diagnostic results from both the GEBT and scintigraphy and found that GEBT results agreed with scintigraphy results 73% to 97% of the time when measured at various time points during the test. No deaths or serious adverse events occurred during clinical studies, but some study participants reported nausea and stomach discomfort during the test. The GEBT is produced by Advanced Breath Diagnostics (Brentwood, TN, USA).

Alberto Gutierrez, PhD, director of the FDA Office of In Vitro Diagnostics and Radiological Health, said, “The GEBT is another option for aiding in the diagnosis of gastroparesis. It can be performed in any clinical setting since it does not require the health care professionals administering the test to undergo special training or to take special precautions related to radiation emitting compounds.”

Related Links:
US Food and Drug Administration
Advanced Breath Diagnostics



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.